Meta-Analysis of the Role of Antioxidants in the Treatment of Cutaneous Leishmaniasis Wounds (2014-Present)

[1] Organization WH. Report of a WHO meeting on
skin-related neglected tropical diseases in West
Meta-Analysis of the Role of Antioxidants in the Treatment of Cutaneous Leishmaniasis Wounds
(2014-Present): 7{15 12
Africa, Geneva, 3-5 October 2022: World Health
Organization; 2023.
[2] Gupta SC, Patchva S, Koh W, Aggarwal BBJC.
Discovery of curcumin, a component of golden
spice, and its miraculous biological activities. J
Clinical experimental pharmacology physiology.
2012;39(3):283-99.
[3] Bashir S, Shabbir K, ud Din F, Khan SU, Ali
Z, Khan BA, et al. Nitazoxanide and quercetin
co-loaded nanotransfersomal gel for topical treat-
ment of cutaneous leishmaniasis with macrophage
targeting and enhanced anti-leishmanial effect. J
Heliyon. 2023;9(11).
[4] Fanti JR, Tomiotto-Pellissier F, Miranda-Sapla
MM, Cataneo AHD, de Jesus Andrade CGT,
Panis C, et al. Biogenic silver nanoparticles
inducing Leishmania amazonensis promastigote
and amastigote death in vitro. J Acta tropica.
2018;178:46-54.
[5] Norouzi R, Mirzaei F, Siyadatpanah A, Sadati
SJAJAJoCM. Evaluation of anti-leishmanial ef-
fect of selenium nanoparticles on Leishmania ma-
jor promastigotes in vitro. J Avicenna Journal of
Clinical Microbiology Infection. 2022;9(3):119-23.
[6] Delavari M, Dalimi A, Ghaffarifar F, Sadraei JJI-
jop. In vitro study on cytotoxic effects of ZnO
nanoparticles on promastigote and amastigote
forms of Leishmania major (MRHO/IR/75/ER).
Iranian journal of parasitology. 2014;9(1):6.
[7] Aghaei M, Aghaei S, Sokhanvari F, Ansari N, Hos-
seini SM, Mohaghegh M-A, et al. The therapeutic
effect of ozonated olive oil plus glucantime on hu-
man cutaneous leishmaniasis. Iranian journal of
basic medical sciences. 2019;22(1):25.
[8] Panahi Y, Fazlolahzadeh O, Atkin SL, Majeed M,
Butler AE, Johnston TP, et al. Evidence of cur-
cumin and curcumin analogue effects in skin dis-
eases: A narrative review. Journal of cellular phys-
iology. 2019;234(2):1165-78.
[9] Amiri Dashatan N, Ashrafmansouri M, Koushki
M, Ahmadi NJJoAiM. Effect of Resveratrol and
its derivatives on Leishmania viability: a meta-
analysis. Journal of Advances in Medical Biomed-
ical Research. 2023;31(144):1-13.
[10] Ahmadi-Renani K, Mahmoodzadeh A, Cheraghali
A, Esfahani AJIJoMS. Effect of garlic extract
on cutaneous leishmaniasis and the role of ni-
tric oxide. Iranian Journal of Medical Sciences.
2015;27(3):97-100.
[11] Upadhyay RKJGMCP. Antiparasitic potential of
plant natural products against protozoans, ne-
matodes and cestodes: A review. Gen Med Clin
Pract,. 2024;7:1-5.
[12] Alvar J, Velez ID, Bern C, Herrero M, Desjeux
P, Cano J, et al. Leishmaniasis worldwide and
global estimates of its incidence. J PloS one.
2012;7(5):e35671.
[13] Molaakbari E, Khosravi A, Salarkia E, Shari  I,
Keyhani A, Bamorovat M, et al. The synergis-
tic anti-leishmanial effect of photodynamic ther-
apy employing chemotherapy-mediated nanocom-
posites. J Scienti c Reports. 2025;15(1):1-18.
[14] El-Khadragy M, Alolayan EM, Metwally DM, El-
Din MFS, Alobud SS, Alsultan NI, et al. Clinical
efficacy associated with enhanced antioxidant en-
zyme activities of silver nanoparticles biosynthe-
sized using Moringa oleifera leaf extract, against
cutaneous leishmaniasis in a murine model of
Leishmania major. International journal of envi-
ronmental research public health. 2018;15(5):1037.
[15] Guerra RO, do Carmo Neto JR, da Silva PEF,
Franco PIR, Barbosa RM, de Albuquerque Mar-
tins T, et al. Metallic nanoparticles and treatment
of cutaneous leishmaniasis: A systematic review.
Journal of Trace Elements in Medicine Biology.
2024;83:127404.
[16] Heras-Mosteiro J, Monge-Maillo B, Pinart M,
Pereira PL, Garcia-Carrasco E, Cuadrado PC, et
al. Interventions for OldWorld cutaneous leishma-
niasis. J Cochrane database of systematic reviews.
2017(11).
[17] Tempone AG, Pieper P, Borborema SE, Theve-
nard F, Lago JHG, Croft SL, et al. Marine al-
kaloids as bioactive agents against protozoal ne-
glected tropical diseases and malaria. J Natural
product reports. 2021;38(12):2214-35.
[18] Mota WJ, Guedes BN, Jain S, Cardoso JC, Sev-
erino P, Souto EBJDPH. Classical and innovative
drugs for the treatment of Leishmania infections.
J Discover Public Health. 2024;21(1):122.
[19] Herrera G, Barragan N, Luna N, Martnez D,
De Martino F, Medina J, et al. An interactive
database of Leishmania species distribution in the
Americas. J Scienti c data. 2020;7(1):110.
[20] Control CfD, P. DPDx-Laboratory identi cation
of parasites of public health concern. J Pthiriasis.
2019.
[21] Brgido HPC, Dos Santos LGA, de Barros RC,
Correa-Barbosa J, Santos PVBd, Paz RFL, et al.
Avicenna Veterinary Research/ Vol. 1, No. 2, Summer 2025 13
The Role of Oxidative Stress in the Pathogene-
sis and Treatment of Leishmaniasis: Impact on
Drug Toxicity and Therapeutic Potential of Nat-
ural Products. J Toxics. 2025;13(3):190.
[22] Frezard F, Monte-Neto R, Reis PGJBr. Antimony
transport mechanisms in resistant leishmania par-
asites. J Biophysical reviews. 2014;6:119-32.
[23] Bailey F, Mondragon-Shem K, Haines LR, Olabi
A, Alor  A, Ruiz-Postigo JA, et al. Cuta-
neous leishmaniasis and co-morbid major depres-
sive disorder: a systematic review with burden
estimates. J PLoS neglected tropical diseases.
2019;13(2):e0007092.
[24] Allahverdiyev AM, Abamor ES, Bagirova M, Us-
tundag CB, Kaya C, Kaya F, et al. Antileish-
manial effect of silver nanoparticles and their
enhanced antiparasitic activity under ultravio-
let light. International journal of Nanomedicine.
2011:2705-14.
[25] Oliveira F, Ba ca A, Rosato AB, Favali CB, Costa
JM, Cafe V, et al. Lesion size correlates with
Leishmania antigen-stimulated TNF-levels in hu-
man cutaneous leishmaniasis. The American jour-
nal of tropical medicine hygiene. 2011;85(1):70.
[26] Upadhyay RK. Antiparasitic potential of plant
natural products against protozoans, nematodes
and cestodes: A review. J Gen. Med. Clin. Pract.
2024;7:1-5.
[27] Borazjani R, Aminnia S, Rastegarian M, Hosseini
M, Ghanbarinasab Z, Ashkani-Esfahani S, et al.
Effect of Hydroalcoholic Extract of Arnebia Eu-
chroma on the Treatment of Cutaneous Leishma-
niasis. Journal of Clinical Diagnostic Research.
2018;12(8).
[28] Majeed QA, Shater AF, Alanazi ADJIJoP. Green
Synthesis, Characterization, and Antileishmanial
Activity of the Silver Nanoparticles Alone and
Along with Meglumine Antimoniate against Leish-
mania major Infection. Iranian Journal of Para-
sitology. 2023;18(4):535.
[29] Shirmohammad S, Mohebali M, Arabkhazaeli F,
Hassan J, Shayan D, Amininia N, et al. Evaluation
of Nanonanoliposomal Curcumin on Cutaneous
Leishmaniasis Skin Lesions Caused by Leishma-
nia major in BALB/c Mice. Iranian Journal of
Parasitology. 2024;19(2):238.
[30] Aronson N, Herwaldt BL, Libman M, Pearson
R, Lopez-Velez R, Weina P, et al. Diagnosis and
treatment of leishmaniasis: clinical practice guide-
lines by the Infectious Diseases Society of Amer-
ica (IDSA) and the American Society of Tropical
Medicine and Hygiene (ASTMH). J Clinical infec-
tious diseases. 2016;63(12):e202-e64.
[31] de Sousa Goncalves R, de Pinho FA, Dinis-
Oliveira RJ, Mendes MO, de Andrade TS, da
Silva Solca M, et al. Nutritional adjuvants with
antioxidant properties in the treatment of ca-
nine leishmaniasis. J Veterinary parasitology.
2021;298:109526.
[32] Fernandez OL, Belew AT, Rosales-Chilama M,
Sanchez-Hidalgo A, Colmenares M, Saravia NG, et
al. Interplay of human macrophage response and
natural resistance of L.(V.) panamensis to pen-
tavalent antimony. J bioRxiv. 2024.10. 29.620724.
[33] Goncalves-Oliveira LF, Souza-Silva F, de Cas-
tro C^ortes LM, Veloso LB, Pereira BAS, Cysne-
Finkelstein L, et al. The combination therapy
of meglumine antimoniate and oxiranes (epoxy--
lapachone and epoxymethyl-lawsone) enhance the
leishmanicidal effect in mice infected by Leish-
mania (Leishmania) amazonensis. International
Journal for Parasitology: Drugs. 2019;10:101-8.
[34] Sundar S, Chakravarty JJEoop. An update on
pharmacotherapy for leishmaniasis. J Expert
opinion on pharmacotherapy. 2015;16(2):237-52.
[35] Blanca P-M, Mara Luisa F-R, Guadalupe M,
Fatima C-LJA. Oxidative stress in canine dis-
eases: a comprehensive review. J Antioxidants.
2024;13(11):1396.
[36] Kopelyanskiy D, Desponds C, Prevel F, Rossi M,
Migliorini R, Snaka T, et al. Leishmania guyanen-
sis suppressed inducible nitric oxide synthase pro-
voked by its viral endosymbiont. J Frontiers in cel-
lular infection microbiology. 2022;12:944819.
[37] Mehrolhasani N, Faramarzpour M, Salarkia E,
Keyhani A, Dabiri S, Meymandi SSJSR. The de-
veloping role of NRF2 and HMOX1 in treatment
response of cutaneous leishmaniasis. J Scienti c
Reports. 2025;15(1):14988.
[38] Bruni N, Stella B, Giraudo L, Della Pepa C,
Gastaldi D, Dosio FJIjon. Nanostructured deliv-
ery systems with improved leishmanicidal activ-
ity: a critical review. International journal of
nanomedicine. 2017:5289-311.
[39] Organization WH. WHO guideline for the treat-
ment of visceral leishmaniasis in HIV co-infected
patients in East Africa and South-East Asia:
World Health Organization; 2022.
[40] Monge-Maillo B, Norman FF, Cruz I, Alvar J,
Lopez-Velez R. Visceral leishmaniasis and HIV
coinfection in the Mediterranean region. J PLoS
neglected tropical diseases. 2014;8(8):e3021.
Meta-Analysis of the Role of Antioxidants in the Treatment of Cutaneous Leishmaniasis Wounds
(2014-Present): 7{15 14
[41] Torres-Guerrero E, Quintanilla-Cedillo M, Ruiz-
Esmenjaud J, Arenas R. Leishmaniasis: a review.
[Version 1] ed: F1000Res 6: 750;2017 May. p. 750.
[42] Youse  M, Zolhavarieh SM, Nourian A, Rezvan H,
Sadeghi-nasab AJIJoVS. Alterations in the Clini-
cal Manifestations of Cutaneous Leishmaniasis in
Various Total Antioxidant Capacities: An Ani-
mal Study Using BALB/c Mice. Iranian Journal of
Veterinary Science and Technology. 2024;16(1):10-
8.
[43] Esmaeeli S, Hoseinirad SM, Rajabian M, Taheri
AR, Berenji F, Hashemy SIJMp. Evaluation
of the oxidant-antioxidant balance, isoprostane
and quantitative CRP in patients with cuta-
neous leishmaniasis. J Microbial pathogenesis.
2019;137:103738.
[44] Oliveira WN, Ribeiro LE, Schrieffer A, Machado
P, Carvalho EM, Bacellar OJC. The role of in am-
matory and anti-in ammatory cytokines in the
pathogenesis of human tegumentary leishmania-
sis. J Cytokine. 2014;66(2):127-32.
[45] Oryan A, Bemani E, Bahrami SJAPJoTB.
Anti-leishmanial, immunomodulatory and anti-
oxidative activity of quercetin against cuta-
neous leishmaniasis caused by Leishmania ma-
jor. Asian Paci c Journal of Tropical Biomedicine.
2023;13(1):26-34.